• Publications
  • Influence
Long‐term results of patients undergoing liver transplantation for primary sclerosing cholangitis
Liver transplantation is the only effective therapeutic option for patients with end‐stage liver disease due to primary sclerosing cholangitis (PSC). In this study, we analyzed a single center'sExpand
  • 288
  • 17
Long‐term outcome of endoscopic treatment of biliary strictures after liver transplantation
Biliary strictures are one of the most common complications following liver transplantation (LT), with an incidence of 5.8‐34%. Endoscopic techniques have been successfully used to treat biliaryExpand
  • 162
  • 13
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome
Orthotopic liver transplantation (OLT) has been considered the best treatment option for patients with hepatocellular carcinoma (HCC). Because of a steadily increasing waiting time, a noteworthyExpand
  • 400
  • 12
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
We aimed to establish an objective point score to guide the decision for retreatment with transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). In all, 222 patientsExpand
  • 193
  • 11
Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment.
Please cite this article as: Kozbial, K., Moser, S., Schwarzer, R., Laferl, H., Al-Zoairy, R., Stauber, R., Stättermayer, A.F., Beinhardt, S., Graziadei, I., Freissmuth, C., Maieron, A., Gschwantler,Expand
  • 154
  • 11
Increased Expression of CCL20 in Human Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) constituting Crohn's disease (CD) and ulcerative colitis (UC) is related to a dysregulated T cell response. CCL20 attracts memory T lymphocytes and dendritic cells.Expand
  • 165
  • 11
Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma
Patients with small hepatocellular carcinoma (HCC) can be cured by liver transplantation (LT). However, many patients drop out during the waiting time as a result of tumor progression. WeExpand
  • 219
  • 9
Recurrence of primary sclerosing cholangitis following liver transplantation
Recurrence of primary sclerosing cholangitis (PSC) following liver transplantation has been suggested; however, it has not been fully defined because of numerous complicating factors and the lack ofExpand
  • 264
  • 9
Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival.
BACKGROUND & AIMS Impaired binding function of albumin has been demonstrated in end-stage liver disease. This and other functional disturbances of albumin may be related to oxidative stress which isExpand
  • 92
  • 9
Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
PURPOSE To compare the efficacies of transarterial chemoembolization (TACE) and sorafenib in patients with advanced-stage hepatocellular carcinoma (HCC). MATERIALS AND METHODS The retrospectiveExpand
  • 142
  • 8